Tag: Amplyx Pharmaceuticals

Mergers and Acquisitions, News

Pfizer Acquires Amplyx Pharmaceuticals

April 29, 2021

Via: Contract Pharma

Pfizer has acquired Amplyx Pharmaceuticals, a privately-held company dedicated to the development of therapies for immune system disorders. Amplyx’s lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections. Financial terms were […]